Erasca (ERAS) Common Equity (2020 - 2026)
Erasca's Common Equity was $361.87 million in Q2 2026, down 2.8% from $372.26 million a year earlier and down 8.0% from the prior quarter.
Powered by 
Analysis
Erasca (ERAS) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Erasca came in at $325.17 million, down 23.2% from FY2024.
- In earlier years, Common Equity was $423.5 million in FY2024 (+33.7%), $316.69 million in FY2023 (-23.1%), $411.85 million in FY2022 (-9.8%) and $456.53 million in FY2021.
- Quarterly Common Equity has moved between $288.41 million (Q1 2024) and $482.99 million (Q3 2021) over five years.
- Compared with a year earlier, Common Equity has declined for five straight quarters, with growth averaging 4.7% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q1 2025 (growth of 38.5%); the worst was Q1 2024 (a decline of 25.4%).
- Per Business Quant data, ERAS's Common Equity in the three quarters before Q2 2026 was $393.53 million (Q1 2026), $325.17 million (Q4 2025) and $347.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Erasca | 4.42 Bn | 4.42 Bn | - | 361.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 361.87 Mn |
| Mar 31, 2026 | 393.53 Mn |
| Dec 31, 2025 | 325.17 Mn |
| Sep 30, 2025 | 347.89 Mn |
| Jun 30, 2025 | 372.26 Mn |
| Mar 31, 2025 | 399.50 Mn |
| Dec 31, 2024 | 423.50 Mn |
| Sep 30, 2024 | 450.04 Mn |
| Jun 30, 2024 | 451.09 Mn |
| Mar 31, 2024 | 288.41 Mn |
| Dec 31, 2023 | 316.69 Mn |
| Sep 30, 2023 | 338.98 Mn |
| Jun 30, 2023 | 362.71 Mn |
| Mar 31, 2023 | 386.45 Mn |
| Dec 31, 2022 | 411.85 Mn |
| Sep 30, 2022 | 365.32 Mn |
| Jun 30, 2022 | 395.07 Mn |
| Mar 31, 2022 | 424.66 Mn |
| Dec 31, 2021 | 456.53 Mn |
| Sep 30, 2021 | 482.99 Mn |
API Access
Erasca Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ERAS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ERAS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ERAS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();